Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Di Stefano

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
The Journal of Nutritional Biochemistry|January 11, 2014
One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humansJosé M Alvarez-Suarez, Francesca Giampieri, Sara Tulipani, et al.
Protein Science : a Publication of the Protein Society|September 14, 2024
Peptides inhibiting the assembly of monomeric human l-lactate dehydrogenase into catalytically active homotetramer decrease the synthesis of lactate in cultured cellsAlessandra Stefan, Luca Gentilucci, Francesca Ruffolo, et al.
European Journal of Medicinal Chemistry|January 21, 2019
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cellsMarinella Roberti, Fabrizio Schipani, Greta Bagnolini, et al.
European Journal of Medicinal Chemistry|January 9, 2024
An <sup>19</sup>F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancerSamuel H Myers, Laura Poppi, Francesco Rinaldi, et al.
Journal of Medicinal Chemistry|February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with OlaparibGreta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Cell Death Discovery|March 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activityMirco Masi, Laura Poppi, Viola Previtali, et al.
European Journal of Physical and Rehabilitation Medicine|April 7, 2021
Effects of robot-assisted gait training on postural instability in Parkinson's disease: a systematic reviewAlessandro Picelli, Marianna Capecci, Mirko Filippetti, et al.
Brain Sciences|January 21, 2023
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-AnalysisAlberto Loro, Margherita Beatrice Borg, Marco Battaglia, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The Journal of Nutritional Biochemistry|January 11, 2014
One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humansJosé M Alvarez-Suarez, Francesca Giampieri, Sara Tulipani, et al.
Protein Science : a Publication of the Protein Society|September 14, 2024
Peptides inhibiting the assembly of monomeric human l-lactate dehydrogenase into catalytically active homotetramer decrease the synthesis of lactate in cultured cellsAlessandra Stefan, Luca Gentilucci, Francesca Ruffolo, et al.
European Journal of Medicinal Chemistry|January 21, 2019
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cellsMarinella Roberti, Fabrizio Schipani, Greta Bagnolini, et al.
European Journal of Medicinal Chemistry|January 9, 2024
An <sup>19</sup>F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancerSamuel H Myers, Laura Poppi, Francesco Rinaldi, et al.
Journal of Medicinal Chemistry|February 11, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with OlaparibGreta Bagnolini, Domenico Milano, Marcella Manerba, et al.
Cell Death Discovery|March 17, 2025
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activityMirco Masi, Laura Poppi, Viola Previtali, et al.
European Journal of Physical and Rehabilitation Medicine|April 7, 2021
Effects of robot-assisted gait training on postural instability in Parkinson's disease: a systematic reviewAlessandro Picelli, Marianna Capecci, Mirko Filippetti, et al.
Brain Sciences|January 21, 2023
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-AnalysisAlberto Loro, Margherita Beatrice Borg, Marco Battaglia, et al.
Pageof 9